Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Generic flu drug threatens Tamiflu
FT.com
Wednesday, May 13, 2009 - 6:01pm
tags:
generics, Tamiful, Cipla, India, Roche
Insmed swings to 1st-quarter profit on sale of assets, facility to Merck
Yahoo/AP
Wednesday, May 13, 2009 - 6:00pm
tags:
Insmed, earnings, Merck
ZymoGenetics cancer drug meets midstage study goal
Yahoo/AP
Wednesday, May 13, 2009 - 6:00pm
tags:
ZymoGenetics, drug trials, skin cancer
Teva Pharmaceutical Industries loses appeal in patent dispute with Procter & Gamble on Actonel
Yahoo/AP
Wednesday, May 13, 2009 - 5:59pm
tags:
Proctor & Gamble, Teva Pharmaceuticals, Actonel
Dendreon says it raised $221M from stock sale
Yahoo/AP
Wednesday, May 13, 2009 - 5:26pm
tags:
Dendreon
Cougar Bio Looking for a Partner?
Yahoo/Zacks.com
Wednesday, May 13, 2009 - 5:25pm
tags:
Cougar Biotechnology, M&A
US prescription drug use fell in 2008, study says
Yahoo/AP
Wednesday, May 13, 2009 - 5:24pm
tags:
drug sales, prescription data
The Novartis Apprentice: You're Hired!
CNBC
Wednesday, May 13, 2009 - 5:23pm
tags:
Novartis
Big Pharma Advances Amid Market Sell Off
Yahoo/Indie Research
Wednesday, May 13, 2009 - 12:10pm
tags:
Big Pharma
4-Star Stocks Poised to Pop: AstraZeneca
Motley Fool
Wednesday, May 13, 2009 - 12:09pm
tags:
AstraZeneca
What Amylin's Established Drugs Are Worth Alone
Seeking Alpha
Wednesday, May 13, 2009 - 9:44am
tags:
Amylin
Neurogen suspends enrollment, cuts staff
Fierce Biotech
Wednesday, May 13, 2009 - 9:36am
tags:
Neurogen, drug trials, layoffs
Marcial: A Biogen Breakup or Buyout?
Businessweek
Wednesday, May 13, 2009 - 9:35am
tags:
Biogen Idec
Johnson & Johnson: Offering Strong Yield and Steady Growth
Seeking Alpha
Wednesday, May 13, 2009 - 9:34am
tags:
JNJ
Has PE-Backed Pharma R&D Risk Hedging Fizzled?
InVivo
Wednesday, May 13, 2009 - 8:35am
tags:
R&D
Medicines Co. stops 2 anti-clotting drug trials
Yahoo/AP
Wednesday, May 13, 2009 - 8:30am
tags:
Medicines Company, anti-clotting, drug trials
Acadia Offers Opportunity
Seeking Alpha
Wednesday, May 13, 2009 - 8:15am
tags:
Acadia, Biovail
POZEN Receives Decision from AstraZeneca to File PN 400 NDA
Yahoo
Wednesday, May 13, 2009 - 8:09am
tags:
AstraZeneca, NDA, Pozen
Provenge Approval: Dendreon CEO Offers Hazy Outlook
Seeking Alpha
Wednesday, May 13, 2009 - 6:56am
tags:
Provenge, Dendreon, FDA, prostate cancer
Cypress Bio Banks on Savella
Yahoo/Zacks.com
Wednesday, May 13, 2009 - 6:54am
tags:
Cypress Bioscience, Savella, Forest Labs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.